ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Pemphigus foliaceus in a patient with gastrointestinal stromal tumor treated with adjuvant imatinib mesylate
Dermatology Online Journal
◽
10.5070/d3266049324
◽
2020
◽
Vol 26
(6)
◽
Author(s):
Hal A Lewis
◽
David Y Chen
◽
Ilana S Rosman
◽
Joel Picus
◽
Milan J Anadkat
Keyword(s):
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Stromal Tumor
◽
Pemphigus Foliaceus
◽
Adjuvant Imatinib
Download Full-text
Related Documents
Cited By
References
Imatinib mesylate-induced pemphigus foliaceus in a patient with gastrointestinal stromal tumor
Current Medical Issues
◽
10.4103/cmi.cmi_25_20
◽
2020
◽
Vol 18
(3)
◽
pp. 245
Author(s):
PriyaJeevamani Chandrasekaran
◽
RohithG Chitrapur
◽
Murali Subramanian
◽
GV Vishnuvardhana
Keyword(s):
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Stromal Tumor
◽
Pemphigus Foliaceus
Download Full-text
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665
Journal of Surgical Oncology
◽
10.1002/jso.21160
◽
2009
◽
Vol 99
(1)
◽
pp. 42-47
◽
Cited By ~ 247
Author(s):
Burton L. Eisenberg
◽
Jonathan Harris
◽
Charles D. Blanke
◽
George D. Demetri
◽
Michael C. Heinrich
◽
...
Keyword(s):
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Phase Ii
◽
Phase Ii Trial
◽
Stromal Tumor
◽
Adjuvant Imatinib
◽
Early Results
Download Full-text
Adjuvant imatinib mesylate in patients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: Safety results from the U.S. Intergroup Phase II trial ACOSOG Z9000
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.9009
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 9009-9009
◽
Cited By ~ 21
Author(s):
R. P. Dematteo
◽
C. R. Antonescu
◽
V. Chadaram
◽
Y. N. You
◽
L. McCall
◽
...
Keyword(s):
High Risk
◽
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Phase Ii
◽
Phase Ii Trial
◽
Complete Resection
◽
Stromal Tumor
◽
Adjuvant Imatinib
◽
The U.S
Download Full-text
Gastrointestinal stromal tumor of the cecum with disseminated omental and pancreatic lesions in a dog treated with surgical resection and adjuvant imatinib mesylate chemotherapy
Journal of Japan Veterinary Cancer Society
◽
10.12951/jvcs.2018-002
◽
2020
◽
Vol 9
(1)
◽
pp. 1-5
Author(s):
Hiroyuki Igarashi
◽
Kyoko Igarashi
Keyword(s):
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Surgical Resection
◽
Stromal Tumor
◽
Adjuvant Imatinib
Download Full-text
Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk, Primary Gastrointestinal Stromal Tumor
Annals of Surgery
◽
10.1097/sla.0b013e3182a15eb7
◽
2013
◽
Vol 258
(3)
◽
pp. 422-429
◽
Cited By ~ 98
Author(s):
Ronald P. DeMatteo
◽
Karla V. Ballman
◽
Cristina R. Antonescu
◽
Christopher Corless
◽
Violetta Kolesnikova
◽
...
Keyword(s):
High Risk
◽
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Stromal Tumor
◽
Long Term Results
◽
Adjuvant Imatinib
Download Full-text
Faculty Opinions recommendation of Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1147293.604446
◽
2009
◽
Author(s):
Florence Duffaud
Keyword(s):
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Phase Ii
◽
Phase Ii Trial
◽
Stromal Tumor
◽
Adjuvant Imatinib
◽
Early Results
Download Full-text
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Long-term follow-up results of RTOG 0132.
Journal of Clinical Oncology
◽
10.1200/jco.2011.29.15_suppl.10057
◽
2011
◽
Vol 29
(15_suppl)
◽
pp. 10057-10057
◽
Cited By ~ 1
Author(s):
D. Wang
◽
Q. Zhang
◽
C. D. Blanke
◽
G. D. Demetri
◽
M. C. Heinrich
◽
...
Keyword(s):
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Phase Ii
◽
Phase Ii Trial
◽
Stromal Tumor
◽
Adjuvant Imatinib
◽
Long Term Follow Up
Download Full-text
Metachronous Primary Adenocarcinoma of Lung During Adjuvant Imatinib Mesylate Therapy for Gastrointestinal Stromal Tumor of Stomach
Medicine
◽
10.1097/md.0000000000001484
◽
2015
◽
Vol 94
(36)
◽
pp. e1484
◽
Cited By ~ 8
Author(s):
Meng-jie Jiang
◽
Shan-Shan Weng
◽
Ying Cao
◽
Xiao-Fen Li
◽
Liu-Hong Wang
◽
...
Keyword(s):
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Stromal Tumor
◽
Primary Adenocarcinoma
◽
Adjuvant Imatinib
◽
Adenocarcinoma Of Lung
Download Full-text
Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up
Journal of Cancer Research and Clinical Oncology
◽
10.1007/s00432-016-2334-x
◽
2017
◽
Vol 143
(4)
◽
pp. 727-734
◽
Cited By ~ 16
Author(s):
Jian-Xian Lin
◽
Qing-Feng Chen
◽
Chao-Hui Zheng
◽
Ping Li
◽
Jian-Wei Xie
◽
...
Keyword(s):
High Risk
◽
Gastrointestinal Stromal Tumor
◽
Imatinib Mesylate
◽
Stromal Tumor
◽
Adjuvant Imatinib
◽
Long Term Follow Up
Download Full-text
Delayed adjuvant imatinib in patients with high risk of recurrence of gastrointestinal stromal tumor after radical surgery: a retrospective cohort study
Journal of Cancer Research and Clinical Oncology
◽
10.1007/s00432-021-03749-6
◽
2021
◽
Author(s):
Wan Qianyi
◽
Xu Mei
◽
Zhao Rui
◽
Wang Yong
◽
Wu Yutao
◽
...
Keyword(s):
Cohort Study
◽
High Risk
◽
Gastrointestinal Stromal Tumor
◽
Retrospective Cohort Study
◽
Retrospective Cohort
◽
Radical Surgery
◽
Stromal Tumor
◽
Adjuvant Imatinib
◽
Risk Of Recurrence
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close